Advertisement
U.S. markets closed

Helius Medical Technologies, Inc. (HSDT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
0.4532+0.0027 (+0.60%)
At close: 04:00PM EST
0.4600 +0.01 (+1.50%)
After hours: 06:56PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.4505
Open0.4630
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4500 - 0.5100
52 Week Range0.3730 - 9.5000
Volume263,028
Avg. Volume451,610
Market Cap1.69M
Beta (5Y Monthly)1.61
PE Ratio (TTM)N/A
EPS (TTM)-4.2700
Earnings DateNov 25, 2024 - Dec 03, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

    Management to host business update call today at 9:00am ETNEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today provided updates on its efforts to achieve fair market access for its Portable Neuromodulation Stimulator (PoNS) device and announced plans to host a business update call today at 9:00am ET. “W

  • GlobeNewswire

    Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives

    NEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced it has initiated a process, in consultation with its financial and legal advisors, to explore a range of strategic alternatives focused on maximizing stockholder value. The deferral of a reimbursement payment determination for the PoNS Contr